CNSP
Price:
$4.7
Market Cap:
$2.70M
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Ph...[Read more]
Industry
Biotechnology
IPO Date
2019-11-08
Stock Exchange
NASDAQ
Ticker
CNSP
According to CNS Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -238.69%. This represents a change of -86.67% compared to the average of -1791.22% of the last 4 quarters.
The mean historical ROE of CNS Pharmaceuticals, Inc. over the last ten years is 172.66%. The current -238.69% ROE has changed -238.24% with respect to the historical average. Over the past ten years (40 quarters), CNSP's ROE was at its highest in in the December 2018 quarter at 1.21%. The ROE was at its lowest in in the September 2019 quarter at -327155.09%.
Average
172.66%
Median
-67.81%
Minimum
-350.48%
Maximum
1.35%
Discovering the peaks and valleys of CNS Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 222.82%
Maximum Annual ROE = 1.35%
Minimum Annual Increase = -326.47%
Minimum Annual ROE = -350.48%
| Year | ROE | Change |
|---|---|---|
| 2025 | -350.48% | 45.70% |
| 2024 | -240.55% | -156.56% |
| 2023 | 425.33% | -326.47% |
| 2022 | -187.81% | -14.20% |
| 2021 | -218.90% | 222.82% |
| 2020 | -67.81% | 32.93% |
| 2019 | -51.01% | -103.79% |
| 2018 | 1.35% | 49.61% |
The current ROE of CNS Pharmaceuticals, Inc. (CNSP) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-55.23%
5-year avg
-114.48%
10-year avg
172.66%
CNS Pharmaceuticals, Inc.’s ROE is greater than Windtree Therapeutics, Inc. (-1302.82%), greater than Pasithea Therapeutics Corp. (-57.44%), greater than NLS Pharmaceutics AG (-100.99%), greater than Soligenix, Inc. (-246.04%), greater than Oragenics, Inc. (-177.32%), greater than 60 Degrees Pharmaceuticals, Inc. (-200.17%), greater than Clearmind Medicine Inc. (-138.23%), greater than Ensysce Biosciences, Inc. (-631.47%), greater than GRI Bio, Inc. (-199.52%), greater than Silo Pharma, Inc. (-88.41%),
| Company | ROE | Market cap |
|---|---|---|
| -1302.82% | $674.18K | |
| -57.44% | $3.72M | |
| -100.99% | $919.60K | |
| -246.04% | $4.12M | |
| -177.32% | $2.48M | |
| -200.17% | $1.32M | |
| -138.23% | $3.13M | |
| -631.47% | $2.52M | |
| -199.52% | $168.88K | |
| -88.41% | $5.54M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CNS Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CNS Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is CNS Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for CNS Pharmaceuticals, Inc. (CNSP)?
What is the highest ROE for CNS Pharmaceuticals, Inc. (CNSP)?
What is the 3-year average ROE for CNS Pharmaceuticals, Inc. (CNSP)?
What is the 5-year average ROE for CNS Pharmaceuticals, Inc. (CNSP)?
How does the current ROE for CNS Pharmaceuticals, Inc. (CNSP) compare to its historical average?